DIRECTSENSE Technology Launched by Boston Scientific
Available on the RHYTHMIA HDx™ Mapping System, the DIRECTSENSE Technology, which received U.S. Food and Drug Administration approval in April, is the only tool to monitor changes in local impedance – electrical resistance – around the tip of the INTELLANAV™ MiFi Open-Irrigated (OI) ablation catheter, offering physicians an additional measurement of therapy effect during an ablation.
FlowSense™, a Wireless, Noninvasive Flow Sensor, Has Been Granted Breakthrough Device Designation by the FDA
The novel technology, formed out of the award-winning John A. Rogers Research Group at Northwestern University (Evanston, IL), is designed to rapidly monitor ventricular shunt function in patients with excess cerebrospinal fluid caused by hydrocephalus
Assisting the World Through Advanced Robotic Technology
Founded in Shimizu, Japan in 1976, Intelligent Actuator Incorporated (IAI) has over forty years of experience in the design and manufacture of customized medical...
Department of Defense Adds Lipogems to Their Arsenal
Through its partnership with Buffalo Supply, Inc., the Lipogems Sports Medicine System is now available within the U.S. Department of Defense (DoD) to help over 2.3 million service members that may be suffering from orthopaedic and wound issues.
New Option to Treat Heavy Menstrual Bleeding Associated with Fibroids in Women
FDA approval was granted to Oriahnn (an estrogen and progestin combination product consisting of elagolix, estradiol and norethindrone acetate) capsules, co-packaged for oral use, for the management of heavy menstrual bleeding associated with uterine leiomyomas (fibroids) in premenopausal women.